Search - tctmd.com

Displaying 1 - 20 of 205

Sort: Relevancy | Date

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

L.A. McKeown

January 21, 2025

Advertisement

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Healthcare Expenses Increase After GLP-1 Prescription

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content